December 16, 2018, Coralville, IA. – Emmyon is pleased to announce that Dr. John Talley has become the company’s Vice President of Chemistry. John has served as senior scientific advisor at Emmyon and led the company’s chemistry program since 2012. He is one of the world’s most accomplished medicinal chemists and an inventor on more than 200 issued U.S. patents. His inventions include the COX-2 specific inhibitors Celebrex®, Bextra®, Dynastat®, Deramaxx® and Trocoxil® and the hydroxyethyl sulfonamide class of inhibitors for the treatment of HIV/AIDS, marketed under the brand names of Agenerase® , Telzir® , and Prezista®. The medicines invented by Dr. Talley have improved the health of millions of patients and generated over $40 billion in sales to date. He received the prestigious PhRMA Discoverers Award in 2002 for the discovery of Celebrex®. For the past four years (2015-2018), Dr. Talley has been named to The Medicine Maker Power List, which recognizes the world’s most influential people in drug discovery and development.